| Krishna Jafa; Peter McElroy; Lisa Fitzpatrick; Craig B.
Borkowf; Robin MacGowan; Andrew Margolis; Ken Robbins; Ae Saekhou
Youngpairoj; Dale Stratford; Alan Greenberg; Jennifer Taussig; R. Luke
Shouse; Madeleine LaMarre; Eleanor McLellan-Lemal; Walid Heneine; Patrick S.
Sullivan HIV prevalence among state prison inmates is
estimated to be more than five time higher than for the general US
population, the study authors noted. However, data on transmission, risk
modification after diagnosis, transmission networks, and antiretroviral
(ARV) resistance within large state prison systems are sparse. In the
current study, investigators analyzed 88 HIV seroconversions reported during
1988-2005 among male prison inmates in Georgia.
The authors analyzed medical and administrative records to
determine HIV testing histories, and they performed a case-crossover
analysis of HIV risks before and after diagnosis. Seroconverters' HIV
strains were studied to identify genetically related transmission clusters
and ARV resistance.
Among all seroconverters, 41 (47 percent) were diagnosed
when voluntary annual HIV testing was offered, from July 2003 to June 2005.
Compared to before their diagnoses, HIV seroconverters were less likely
after diagnosis to report sex (odds ratio [OR]=0.02, 95 percent confidence
interval [CI]: 0-0.10) and tattooing (OR=0.03, 95 percent CI: less than
0.01-0.20) in prison. Of 67 seroconverters' specimens tested, 33 (49
percent) fell into one of 10 genetically related clusters. Among these, 25
(76 percent) reported sex in prison before their diagnosis. The viral
strains of eight out of 13 (61 percent) ARV-naïve prisoners were
ARV-resistant, as were 21 out of 52 (40 percent) ARV-experienced prisoners.
"Half of all HIV seroconversions were identified when
routine voluntary testing was offered, and seroconverters reduced their
risks following their diagnosis," concluded the authors. "Most genetically
related seroconverters reported sex in prison, suggesting HIV transmission
through sexual networks. Resistance testing before initiating antiretroviral
therapy is important for newly diagnosed inmates." |